{"id":3624,"date":"2024-07-03T17:50:28","date_gmt":"2024-07-03T14:50:28","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=3624"},"modified":"2024-07-03T17:50:29","modified_gmt":"2024-07-03T14:50:29","slug":"humanisin-ar-ge-merkezi-10-yilini-kutluyor","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=3624","title":{"rendered":"Humanis\u2019in Ar-Ge Merkezi 10. Y\u0131l\u0131n\u0131 Kutluyor"},"content":{"rendered":"\n

Humanis, Ar-Ge merkezinin 10. y\u0131l\u0131n\u0131 kutlaman\u0131n gururunu ya\u015f\u0131yor. 200’den fazla ruhsatland\u0131r\u0131lm\u0131\u015f \u00fcr\u00fcnle T\u00fcrk t\u0131bb\u0131na insan odakl\u0131 sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleri sunan Humanis, QbD (Quality by Design), EMA (Avrupa \u0130la\u00e7 Ajans\u0131) ve ICH (Uluslararas\u0131 Uyum Konseyi) d\u00fczenlemelerine uygun Ar-Ge faaliyetleriyle T\u00fcrk ila\u00e7 sekt\u00f6r\u00fcn\u00fcn ilerleyi\u015fine katk\u0131 vermeye devam ediyor. “Toplum taraf\u0131ndan say\u0131lmak i\u00e7in, topluma sayg\u0131 g\u00f6ster ve de\u011fer \u00fcret” s\u00f6zleriyle Humanis Ar-Ge merkezinin yenilik\u00e7ilik felsefesini \u00f6zetleyen Yunus Sancak, 10 farkl\u0131 tedavi alan\u0131nda T\u00fcrk t\u0131bb\u0131na hizmet verdiklerini, uyuz tedavisine yeni bir tedavi modeli kazand\u0131rd\u0131klar\u0131n\u0131 ve nadir hastal\u0131k olan Serebrotendin\u00f6z Ksantomatozis’in tedavisine y\u00f6nelik \u00fcr\u00fcn\u00fc T\u00fcrk t\u0131bb\u0131na kazand\u0131rarak 10\u2019uncu y\u0131llar\u0131n\u0131 geride b\u0131rakt\u0131klar\u0131n\u0131 ifade etti.<\/strong><\/p>\n\n\n\n

Sanayi ve Teknoloji Bakanl\u0131\u011f\u0131<\/strong> taraf\u0131ndan te\u015fvik edilen en b\u00fcy\u00fck be\u015f ila\u00e7 Ar-Ge merkezinden biri olarak kabul edilen Humanis Ar-Ge merkezi 10\u2019uncu y\u0131l\u0131n\u0131 kutluyor. Bu 10 y\u0131l i\u00e7erisinde QbD<\/strong> (Quality by Design), EMA<\/strong> (Avrupa \u0130la\u00e7 Ajans\u0131) ve ICH<\/strong> (Uluslararas\u0131 Uyum Konseyi) d\u00fczenlemelerine tam uyum sa\u011flamay\u0131 ba\u015faran Humanis Ar-Ge merkezi yakla\u015f\u0131k 200 \u00fcr\u00fcn ve 100\u2019den fazla molek\u00fcl\u00fc T\u00fcrk t\u0131bb\u0131na kazand\u0131rd\u0131. Ara\u015ft\u0131rma ve geli\u015ftirme faaliyetlerinin bir sonucu olarak uyuz tedavisine y\u00f6nelik inovatif bir \u00fcr\u00fcn olan ivermektin etken maddeli oral tableti T\u00fcrk t\u0131bb\u0131n\u0131n hizmetine sunan Humanis Ar-Ge merkezi, Serebrotendin\u00f6z Ksantomatozis’in tedavisine y\u00f6nelik \u00fcr\u00fcn\u00fcyle nadir hastal\u0131klar alan\u0131nda da giri\u015f yapt\u0131. 10 y\u0131l i\u00e7erisinde 10 tedavi alan\u0131n\u0131 kapsayan geni\u015f bir yelpazede ara\u015ft\u0131rma ve geli\u015ftirme \u00e7al\u0131\u015fmalar\u0131 yapan Humanis, 2030 y\u0131l\u0131na kadar farkl\u0131 tedavi alanlar\u0131na girerek daha fazla hayat\u0131 iyile\u015ftirmek i\u00e7in \u00e7al\u0131\u015fmalar\u0131na devam edecek.<\/p>\n\n\n\n

10 y\u0131ll\u0131n sonunda Ar-Ge merkezinin geldi\u011fi noktada en b\u00fcy\u00fck pay\u0131n \u00e7al\u0131\u015fma arkada\u015flar\u0131na ait oldu\u011funu belirten Humanis CEO\u2019su Yunus Sancak, insan\u0131n Humanis i\u00e7in en \u00f6nemli de\u011fer oldu\u011funu, yetkin ve do\u011fru insanlarla \u00e7al\u0131\u015farak kalite \u00e7\u0131tas\u0131n\u0131 her zaman ulusal ve uluslararas\u0131 standartlar\u0131n en \u00fcst \u00e7izgisinde tutmay\u0131 ba\u015fard\u0131klar\u0131n\u0131n alt\u0131n\u0131 \u00e7izdi.<\/p>\n\n\n\n

T\u00fcrk T\u0131bb\u0131na Hizmetle Ge\u00e7en 10 Sene<\/strong><\/p>\n\n\n\n

Humanis Ar-Ge Merkezi<\/strong>\u2019nin, ge\u00e7ti\u011fimiz on y\u0131lda a\u011fr\u0131 kesici ve ate\u015f d\u00fc\u015f\u00fcr\u00fcc\u00fclerden dermatolojiye, antigribal ila\u00e7lardan kalp-damar sa\u011fl\u0131\u011f\u0131na, antiviral tedavilerden kas-iskelet sistemi ila\u00e7lar\u0131na, sindirim sistemi ve solunum yolu hastal\u0131klar\u0131na kadar geni\u015f bir yelpazede projeler geli\u015ftirdi\u011finden bahseden Yunus Sancak, \u201cBu on y\u0131ll\u0131k s\u00fcre\u00e7te 200 ilac\u0131n ruhsatland\u0131rma s\u00fcre\u00e7lerini tamamlayarak ve 100\u2019den fazla molek\u00fcl geli\u015ftirerek T\u00fcrk t\u0131bb\u0131nda g\u00fcvenilen ve sevilen bir sa\u011fl\u0131k markas\u0131 olma hedefinde kararl\u0131l\u0131kla ilerliyoruz\u201d<\/strong> dedi.<\/p>\n\n\n\n

Sa\u011fl\u0131k Sekt\u00f6r\u00fcne \u00d6nemli Katk\u0131larla Dolu 10 Y\u0131l <\/strong><\/strong><\/p>\n\n\n\n

Humanis Ar-Ge merkezinin 2030 y\u0131l\u0131na kadar merkezi sinir sistemi hastal\u0131klar\u0131, diyabet, kardiyoloji ve onkoloji alanlar\u0131nda \u00fcr\u00fcnler geli\u015ftirece\u011fini a\u00e7\u0131klayan Yunus Sancak, \u201cG\u00fcvenilen ve sevilen bir sa\u011fl\u0131k markas\u0131 olma yolundaki on y\u0131ll\u0131k s\u00fcreci geride b\u0131rakt\u0131k. Bu 10 y\u0131lda s\u00fcrekli inovasyona \u00f6nem vererek yepyeni etkili \u00e7\u00f6z\u00fcmler geli\u015ftirmeye odakland\u0131k. \u0130novasyon, rekabet g\u00fcc\u00fcm\u00fcz\u00fc art\u0131r\u0131rken, insan odakl\u0131 sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleriyle sa\u011fl\u0131\u011f\u0131 daha fazla insan i\u00e7in eri\u015filebilir k\u0131lma potansiyelimizi art\u0131r\u0131yor\u201d <\/strong>dedi. <\/strong>Humanis Ar-Ge merkezinin mevcut yenilik\u00e7i faaliyetlerini \u201cBug\u00fcne kadarki ara\u015ft\u0131rmalar\u0131m\u0131z\u0131n bir sonucu olarak Ar-Ge merkezimiz ivermektin etken maddesiyle \u00fcretti\u011fi oral tablet \u00fcr\u00fcn\u00fcyle T\u00fcrk t\u0131bb\u0131nda bir ilki ger\u00e7ekle\u015ftirdi. Bununla birlikte nadir bir hastal\u0131k olan Serebrotendin\u00f6z Ksantomatozis’in tedavisine y\u00f6nelik \u00fcr\u00fcn\u00fcm\u00fcz\u00fc T\u00fcrk t\u0131bb\u0131n\u0131n hizmetine sunarak nadir hastal\u0131klar alan\u0131na da giri\u015f yapt\u0131k\u201d <\/strong>s\u00f6zleriyle a\u00e7\u0131klayan Yunus Sancak, \u201c2030 y\u0131l\u0131na kadar yeni tedavi alanlar\u0131na girerek insan odakl\u0131 felsefesi ile sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleri sunmaya devam edece\u011fiz\u201d<\/strong> dedi.<\/p>\n\n\n\n

Yol Arkada\u015flar\u0131m\u0131zla Birlikte Ba\u015fard\u0131k<\/strong><\/p>\n\n\n\n

10 y\u0131ll\u0131k Ar-Ge s\u00fcre\u00e7lerindeki ba\u015far\u0131 s\u0131rr\u0131n\u0131n \u00e7al\u0131\u015fma arkada\u015flar\u0131n\u0131n emeklerinde gizli oldu\u011funu vurgulayan Yunus Sancak, <\/a>\u201c\u0130nsan, Humanis\u2019in en \u00f6nemli de\u011feridir. Mesai yapt\u0131\u011f\u0131m\u0131z arkada\u015flar\u0131m\u0131z\u0131 yol arkada\u015flar\u0131m\u0131z olarak g\u00f6r\u00fcyor<\/strong>, ili\u015fkilerimizi g\u00fcvene, sevgiye ve sayg\u0131ya dayand\u0131r\u0131yoruz. Hepsinin varl\u0131klar\u0131 ve emekleri tek tek \u00e7ok de\u011ferli. Bu de\u011ferler \u00fczerine in\u015fa edilen kurum k\u00fclt\u00fcr\u00fcm\u00fcz sayesinde Humanis\u2019te ve Ar-Ge merkezimizde y\u0131llard\u0131r yetkin ve do\u011fru insanlarla \u00e7al\u0131\u015f\u0131yoruz<\/a>. Bu 10 y\u0131ll\u0131k ara\u015ft\u0131rma ve geli\u015ftirme yolculu\u011fumuz boyunca elimizden gelenin en iyisini ortaya koyarak T\u00fcrk t\u0131bb\u0131nda vazge\u00e7ilmez bir konuma ula\u015ft\u0131k\u201d <\/strong>s\u00f6zleriyle \u00e7al\u0131\u015fma arkada\u015flar\u0131n\u0131n Humanis i\u00e7in anlam\u0131ndan s\u00f6z eden Yunus Sancak \u201cAr-Ge merkezimizin kalite \u00e7\u0131tas\u0131n\u0131 her zaman ulusal ve uluslararas\u0131 standartlar\u0131n en \u00fcst \u00e7izgisinde tutan de\u011ferli yol arkada\u015flar\u0131m\u0131n hepsine te\u015fekk\u00fcr ederim\u201d <\/strong>s\u00f6zleri ile \u00e7al\u0131\u015fma arkada\u015flar\u0131na te\u015fekk\u00fcr etti.<\/strong><\/p>\n\n\n\n

Humanis, bilimsel m\u00fckemmeliyet ve inovasyona olan ba\u011fl\u0131l\u0131\u011f\u0131 ile T\u00fcrkiye\u2019nin ila\u00e7 ve sa\u011fl\u0131k alan\u0131ndaki geli\u015fimine katk\u0131da bulunmaya devam ediyor. G\u00fcvenilen ve sevilen bir sa\u011fl\u0131k markas\u0131 olma vizyonuyla insan odakl\u0131 sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleri sunan Humanis, T\u00fcrk t\u0131bb\u0131na hizmet etmeye devam edecek.<\/p>\n","protected":false},"excerpt":{"rendered":"

Humanis, Ar-Ge merkezinin 10. y\u0131l\u0131n\u0131 kutlaman\u0131n gururunu ya\u015f\u0131yor. 200’den fazla ruhsatland\u0131r\u0131lm\u0131\u015f \u00fcr\u00fcnle T\u00fcrk t\u0131bb\u0131na insan odakl\u0131 sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleri sunan Humanis, QbD (Quality by Design), EMA (Avrupa \u0130la\u00e7 Ajans\u0131) ve ICH (Uluslararas\u0131 Uyum Konseyi) d\u00fczenlemelerine uygun Ar-Ge faaliyetleriyle T\u00fcrk ila\u00e7 sekt\u00f6r\u00fcn\u00fcn ilerleyi\u015fine katk\u0131 vermeye devam ediyor. “Toplum taraf\u0131ndan say\u0131lmak i\u00e7in, topluma sayg\u0131 g\u00f6ster ve de\u011fer \u00fcret” s\u00f6zleriyle Humanis Ar-Ge merkezinin yenilik\u00e7ilik felsefesini \u00f6zetleyen Yunus Sancak, 10 farkl\u0131 tedavi alan\u0131nda T\u00fcrk t\u0131bb\u0131na hizmet verdiklerini, uyuz tedavisine yeni bir tedavi modeli kazand\u0131rd\u0131klar\u0131n\u0131 ve nadir hastal\u0131k olan Serebrotendin\u00f6z Ksantomatozis’in tedavisine y\u00f6nelik \u00fcr\u00fcn\u00fc T\u00fcrk t\u0131bb\u0131na kazand\u0131rarak 10\u2019uncu y\u0131llar\u0131n\u0131 geride b\u0131rakt\u0131klar\u0131n\u0131 ifade etti.<\/p>\n","protected":false},"author":1,"featured_media":3625,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,3],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3624"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3624"}],"version-history":[{"count":1,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3624\/revisions"}],"predecessor-version":[{"id":3626,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3624\/revisions\/3626"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/3625"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}